The drug maker had registered a net profit of Rs 37.53 crore in the quarter ending June 30 in 2014-15.
The company’s net sales went up by 11.17 percent to Rs 479.20 crore in quarter 1 of 2015-16, as against the figure of 431.03 crore in the same period in 2014-15.